Menu Search
Equities

Conmed Corp

CNMD:NYQ

Conmed Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)74.51
  • Today's Change2.80 / 3.90%
  • Shares traded146.44k
  • 1 Year change-30.94%
  • Beta1.4620
Data delayed at least 15 minutes, as of Nov 22 2024 19:13 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Conmed Corp grew revenues 19.06% from 1.05bn to 1.24bn while net income improved from a loss of 80.58m to a gain of 64.46m.
Gross margin55.65%
Net profit margin10.23%
Operating margin15.37%
Return on assets5.68%
Return on equity15.24%
Return on investment6.62%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Conmed Corp fell by 4.65m. However, the company earned 125.35m from its operations for a Cash Flow Margin of 10.07%. In addition the company used 20.03m on investing activities and also paid 110.43m in financing cash flows.
Cash flow per share6.54
Price/Cash flow per share10.88
Book value per share30.21
Tangible book value per share-16.17
More ▼

Balance sheet in USDView more

Conmed Corp has a Debt to Total Capital ratio of 50.21%, a lower figure than the previous year's 118.33%.
Current ratio2.27
Quick ratio1.06
Total debt/total equity1.01
Total debt/total capital0.5021
More ▼

Growth rates in USD

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items increased 176.17%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)0.71%
Div growth rate (5 year)0.00%
Payout ratio (TTM)18.71%
EPS growth(5 years)8.12
EPS (TTM) vs
TTM 1 year ago		126.92
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.